1. Department of Chemistry,
Drug Discovery and Development Centre (H3D), University of Cape Town, Rondebosch 7701, South Africa
2. SAMRC/NHLS/UCT Molecular Mycobacteriology Research Unit, Department
of Pathology, University of Cape Town, Rondebosch 7701, South Africa
3. Institute of Infectious Disease and Molecular
Medicine, University of Cape Town, Rondebosch 7701, South Africa
4. Department of Medicine, Division of Clinical Pharmacology, Drug Discovery
and Development Centre (H3D), University of Cape Town, Observatory, 7925, South Africa
5. Tuberculosis Research Section, Laboratory
of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892, United States
6. DST/NRF Centre of Excellence for Biomedical TB Research,
SA MRC Centre for TB Research, Division of Molecular Biology and Human
Genetics, Faculty of Health Sciences, Stellenbosch University, 7505 Tygerberg, South Africa
7. CJH Consultants, Ford Cottage, South Weirs, Brockenhurst, Hampshire SO42 7UQ, U.K.
8. Strategic Health Innovation Partnerships (SHIP), South African Medical Research Council, Parow Valley, Cape Town, South Africa
9. Cellzome GmbH, Molecular Discovery Research, GlaxoSmithKline, Meyerhofstrasse 1, Heidelberg 69117, Germany
10. Diseases of the Developing
World, GlaxoSmithKline, Calle Severo Ochoa 2, 28760 Tres Cantos, Madrid, Spain
11. South African Medical Research Council
Drug Discovery and Development Research Unit, Department of Chemistry, University of Cape Town, Rondebosch 7701, South Africa